As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...
A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...
Novo Nordisk is working on a new obesity drug that could help patients shed ... could reignite Novo shares. Semaglutide ...
Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to ...
Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...
A recent poll found that about 15.5 million Americans have used injectable diabetes medicines like Ozempic and Wegovy to lose ...
For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...